-
Stress heightens risk of cardiovascular disease in people with anxiety and depression
17 Dec 2025 16:47 GMT
… that are active against drug-resistant strains.
Today, … how one of the drugs was developed, through a new …
Stress heightens risk of cardiovascular disease in people with anxiety … treatments to see if stress-reduction therapies, anti-inflammatory medications, …
-
<![CDATA[SleepRes wins FDA clearance for new sleep apnea device]]>
17 Dec 2025 21:03 GMT
… Airway Pressure technology to treat obstructive sleep apnea … apnea is associated with cardiovascular disease, diabetes, stroke, depression … the gold standard for treating obstructive sleep apnea, … , have also expanded treatment options for certain patient …
-
FDA approves Lerochol as monthly PCSK9 inhibitor for hypercholesterolemia
17 Dec 2025 17:51 GMT
… such as those with established cardiovascular disease and HeFH. In the … LDL-C targets. The drug also lowered apolipoprotein B … inhibitors that are in development, which generally require daily … C reduction.
Despite current treatments with statins, ezetimibe, and …
-
Huxley Medical Announces Commercial Launch of FDA-Cleared Central Sleep Apnea Detection and Appointment of Medical Director of Sleep Medicine
17 Dec 2025 15:57 GMT
… .S. Food and Drug Administration (FDA) 510(k) clearance … prevalent in patients with cardiovascular disease such as heart … it can significantly alter treatment decisions. This is an … proprietary expertise in biosensor development, physiological signal analysis, …
-
Advances in Microneedle Drug Delivery for Obesity: Mechanisms, Applications, and Perspectives
17 Dec 2025 15:25 GMT
… across both developed and developing countries. … mellitus (T2DM), cardiovascular diseases, nonalcoholic fatty … properties for treating Vibrio vulnificus … drug delivery system: an innovative platform enhancing rheumatoid arthritis treatment. Biomed. Pharmacother …
-
Optimal Propofol Dose with Oxycodone for Visceral Pain Relief in Anxious Patients Undergoing Abortion: A Clinical Trial Report
17 Dec 2025 15:25 GMT
… to contribute to the development of more personalized … known allergies to the treatment drugs, evident difficult airways, … Z: chronic Pain-Associated Cardiovascular Disease: the Role of Sympathetic … safety of oxycodone in treating the uterine contraction …
-
Hanmi Pharm Seeks Approval for Obesity Drug Efpeglenatide
17 Dec 2025 13:42 GMT
… Innovative drug Fast … trial conducted on 448 Korean subjects, the efpeglenatide treatment … cardiovascular diseases, and is developing efpeglenatide not limited to obesity treatment … treatment model that enhances therapeutic effects by combining pharmaceuticals …
-
Enveda Announces US FDA IND Clearance and First Patient Dosed in Phase 1 Trial of ENV-308, a First-in-Class Oral Therapy for Obesity; Appoints Nadeem Sarwar, Ph.D., MPharm, MPhil, to Lead Metabolic Disease Strategy
17 Dec 2025 13:34 GMT
… development of a new generation of small-molecule drugs … US Food and Drug Administration (FDA) has cleared the … statins were used in cardiovascular disease.
“Obesity is a … RESEARCH TECHNOLOGY FDA CLINICAL TRIALS BIOTECHNOLOGY PHARMACEUTICAL HEALTH SCIENCE …
-
SleepRes Receives FDA Clearance for its Kricket™ Positive Airway Pressure (PAP) Device with KPAP™
17 Dec 2025 13:34 GMT
… health consequences such as cardiovascular disease, diabetes, stroke, … to scale manufacturing, developing clinical partnerships, and … to transforming the treatment of obstructive sleep … FDA MEDICAL DEVICES HOSPITALS HEALTH TECHNOLOGY OTHER HEALTH PHARMACEUTICAL …
-
The EU presents its “Safe Hearts” plan: the goal is to combat cardiovascular disease
16 Dec 2025 19:27 GMT
… tide and improve prevention and treatment, the European Commission has … Member States in developing national plans to combat cardiovascular diseases. The initiatives against … Among the main causes of cardiovascular disease are also over-processed foods …